CLARIVATE PLC
Ticker: 1764046
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 585.50-6.0% | 623.10+0.3% | 621.40+4.7% | 593.70-4.6% | 622.20-4.3% | 650.30+4.7% | 621.20-4.0% | 647.20 |
| Total Income | 585.50-6.0% | 623.10+0.3% | 621.40+4.7% | 593.70-4.6% | 622.20-4.3% | 650.30+4.7% | 621.20-4.0% | 647.20 |
| EXPENSES | ||||||||
| Expenditure | 555.30-4.1% | 579.10-5.8% | 614.50+0.0% | 614.50+2.3% | 600.50-32.6% | 890.30+44.5% | 616.20+10.0% | 560.00 |
| Tax | 11.40+200.0% | 3.80-69.1% | 12.30-34.6% | 18.80+24.5% | 15.10+322.1% | -6.80-145.3% | 15.00-3.8% | 15.60 |
| PROFIT | ||||||||
| PBT | -28.80-17.6% | -24.50+59.0% | -59.70+29.8% | -85.10-68.5% | -50.50+83.8% | -311.10-418.5% | -60.00-315.1% | 27.90 |
| Net Profit | -40.20-42.0% | -28.30+60.7% | -72.00+30.7% | -103.90-58.4% | -65.60+78.4% | -304.30-305.7% | -75.00-709.8% | 12.30 |
| KEY METRICS | ||||||||
| OPM % | 5.16%-1.90pp | 7.06%+5.95pp | 1.11%+4.61pp | -3.50%-6.99pp | 3.49%+40.39pp | -36.91%-37.71pp | 0.81%-12.67pp | 13.47% |
| NPM % | -6.87%-2.32pp | -4.54%+7.04pp | -11.59%+5.91pp | -17.50%-6.96pp | -10.54%+36.25pp | -46.79%-34.72pp | -12.07%-13.97pp | 1.90% |
| EPS | -0.06-50.0% | -0.04+63.6% | -0.11+26.7% | -0.15-66.7% | -0.09+80.4% | -0.46-228.6% | -0.14-1300.0% | -0.01 |
Corporate Events
Board MeetingCLVT
20263Jul
Board Meeting
Clarivate Plc agrees to sell its Life Sciences and Healthcar…
SEC Filing ↗ Board MeetingCLVT
20269Jun
Board Meeting
Maroun S. Mourad departs as President, Intellectual Property…
SEC Filing ↗ Board MeetingCLVT
202614May
Board Meeting
Shareholders voted on the election of directors, advisory ap…
SEC Filing ↗